› Forums › General Melanoma Community › “Ipi” Survey
- This topic is empty.
- Post
-
- March 17, 2011 at 7:03 pm
As the FDA comes closer to reaching a decision on the investigational drug, Ipilimumab (will be called Yervoy), the MRF will likely receive requests from newspaper or television reporters to speak with patients who have either been on the treatment or whose treatment decisions might be affected by the FDA’s decision. If you have taken this drug or may consider this treatment if it comes to market, and you are willing to share your story, please take a moment to fill out the following survey: http://www.surveymonkey.com/s/DRLM2
As the FDA comes closer to reaching a decision on the investigational drug, Ipilimumab (will be called Yervoy), the MRF will likely receive requests from newspaper or television reporters to speak with patients who have either been on the treatment or whose treatment decisions might be affected by the FDA’s decision. If you have taken this drug or may consider this treatment if it comes to market, and you are willing to share your story, please take a moment to fill out the following survey: http://www.surveymonkey.com/s/DRLM2K3.
Your participation in this survey will help our PR firm find patients who are willing to assist them as they begin media outreach efforts in advance of the FDA’s decision on Yervoy.
- You must be logged in to reply to this topic.